D36-28983-66205 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-08-24
Dose 1 — Pfizer-BioNTech
2021-09-14
Registered in v-safe
2021-09-14
Dose 2 — Pfizer-BioNTech
2021-09-14
Health check-in — day 0, dose 2
Feeling: Good · Site: Pain · Nausea, Diarrhea

Adult check-in
2021-09-16
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-09-17
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Nausea, Diarrhea

Adult check-in
2021-09-18
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Diarrhea · Be unable to do your normal daily activities

Adult check-in
2021-09-21
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-09-28
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-10-05
Survey response — day 21, dose 2
MedDRA: Dyspnoea, Headache, Heart rate increased — Feeling: Poor · Be unable to do your normal daily activities

Free text: Shortness of breath, headaches, elevated heart rate

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-08-24	Pfizer-BioNTech	No
2	2021-09-14	Pfizer-BioNTech	No

Free text

Release 10 — day 21, dose 2

2021-10-05

Symptoms: Shortness of breath, headaches, elevated heart rate

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Dyspnoea	·	·	✓
SD	Headache	·	·	✓
SD	Heart rate increased	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release